Skip to search formSkip to main contentSkip to account menu

tazobactam

Known as: (2S,3S,5R)-3-Methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 4,4-dioxide, TAZO 
A penicillanic acid sulfone derivative and beta-lactamase inhibitor with antibacterial activity. Tazobactam contains a beta-lactam ring and… 
National Institutes of Health

Related topics

Related topics

18 relations

Broader (3)

Anti-Bacterial AgentsPenicillanic Acidbeta-Lactamase Inhibitors
Piperacillin 3000 MG / tazobactam 375 MG InjectionPiperacillin 3000 MG / tazobactam 375 MG Injection [Zosyn]Piperacillin 4000 MG / tazobactam 500 MG InjectionPiperacillin+Tazobactam:Susc:Pt:Isolate:OrdQn

Narrower (4)

YTR 830YTR-830HZerbaxaZosyn

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Rapid Detection of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae from Urine Samples by Use of the ESBL NDP Test
ABSTRACT From June to September 2012, 500 urine samples were recovered from patients with urinary tract infections (UTI) due to… 
Highly Cited
2011
Highly Cited
2011
Chryseobacterium indologenes infection in a newborn: a case report
IntroductionChryseobacterium indologenes is an uncommon human pathogen. Most infections have been detected in hospitalized… 
2011
2011
Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
Highly Cited
2009
Highly Cited
2009
MYSTIC Europe 2007: activity of meropenem and other broad-spectrum agents against nosocomial isolates.
2009
2009
Selection of TNF-alpha binding affibody molecules using a beta-lactamase protein fragment complementation assay.
2007
2007
Antibiotic resistance surveillance over a 4-year period (2000-2003) in Turkey: results of the MYSTIC Program.
Highly Cited
2004
Highly Cited
2004
Replacement of Broad-Spectrum Cephalosporins by Piperacillin-Tazobactam: Impact on Sustained High Rates of Bacterial Resistance
ABSTRACT We have previously observed a significant reduction of ceftriaxone resistance in Proteus mirabilis associated with an… 
Highly Cited
2003
Highly Cited
2003
Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials: report from the MYSTIC Program (2002) in North America.
Highly Cited
2002
Highly Cited
2002
Spectrum and antibiotic resistance of uropathogens from hospitalized patients with urinary tract infections: 1994-2000.
Highly Cited
1999
Highly Cited
1999
Natural antibiotic susceptibility of Escherichia coli, Shigella, E. vulneris, and E. hermannii strains.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)